Scinovex
review Open AccessTop 1% cited

Role of Matrix Metalloproteinases in Angiogenesis and Cancer

Frontiers in Oncology · 2019 · Vol. 9 · pp. 1370–1370
Saray Quintero-FabiánRodrigo ArreolaEnrique Becerril‐VillanuevaJulio César Torres‐RomeroVíctor Ermilo Arana‐ArgáezJulio Lara‐RiegosMario Alberto Ramírez-CamachoMaría Elizbeth Álvarez-Sánchez

Abstract

During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.

Protease and Inhibitor MechanismsAngiogenesis and VEGF in CancerPeptidase Inhibition and AnalysisMatrix metalloproteinaseAngiogenesisExtracellular matrixBasement membraneNeovascularizationMetastasisCell biologyCancer researchDownregulation and upregulationMMP2

Funding

  • Universidad Autónoma de la Ciudad de México
  • Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
Citations
1,005
FWCI
33.54
field-weighted impact
References
219
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.